nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement of reviewers 2019
|
|
|
|
85 |
1 |
p. 241-244 |
artikel |
2 |
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions
|
de Rouw, Nikki |
|
|
85 |
1 |
p. 231-235 |
artikel |
3 |
Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma
|
Liu, Juanfang |
|
|
85 |
1 |
p. 69-76 |
artikel |
4 |
Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer
|
Zhao, Yang |
|
|
85 |
1 |
p. 77-93 |
artikel |
5 |
Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials
|
Xu, Zhou |
|
|
85 |
1 |
p. 61-67 |
artikel |
6 |
Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
|
Yamaguchi, Ou |
|
|
85 |
1 |
p. 237-239 |
artikel |
7 |
Discovery of hPRDX5-based peptide inhibitors blocking PD-1/PD-L1 interaction through in silico proteolysis and rational design
|
Zou, Sen |
|
|
85 |
1 |
p. 185-193 |
artikel |
8 |
Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach
|
Zhou, Chenfei |
|
|
85 |
1 |
p. 113-119 |
artikel |
9 |
Editorial
|
Beumer, Jan H. |
|
|
85 |
1 |
p. 1 |
artikel |
10 |
Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy
|
Rossi, Luigi |
|
|
85 |
1 |
p. 105-111 |
artikel |
11 |
Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development
|
Pattarawat, Pawat |
|
|
85 |
1 |
p. 141-152 |
artikel |
12 |
Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation
|
Huang, Haidi |
|
|
85 |
1 |
p. 195-204 |
artikel |
13 |
Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan
|
Poorebrahim, Mansour |
|
|
85 |
1 |
p. 153-171 |
artikel |
14 |
Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin
|
Meng, Liwei |
|
|
85 |
1 |
p. 3-7 |
artikel |
15 |
Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B
|
Yuki, Satoshi |
|
|
85 |
1 |
p. 217-223 |
artikel |
16 |
Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
|
Huang, Liang |
|
|
85 |
1 |
p. 205-215 |
artikel |
17 |
Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma
|
Garwood, Melissa J. |
|
|
85 |
1 |
p. 133-140 |
artikel |
18 |
PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity
|
Fontaine, Shaun D. |
|
|
85 |
1 |
p. 225-229 |
artikel |
19 |
Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia
|
Medellin-Garibay, Susanna E. |
|
|
85 |
1 |
p. 21-31 |
artikel |
20 |
Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors
|
Jung, Su Young |
|
|
85 |
1 |
p. 173-183 |
artikel |
21 |
Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors
|
Schett, Anne |
|
|
85 |
1 |
p. 121-131 |
artikel |
22 |
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development
|
Angius, Gesuino |
|
|
85 |
1 |
p. 9-20 |
artikel |
23 |
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia
|
Li, Hui |
|
|
85 |
1 |
p. 95-103 |
artikel |
24 |
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)
|
Kashani, Bahareh |
|
|
85 |
1 |
p. 47-59 |
artikel |
25 |
The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approach
|
Sentürk, Melih |
|
|
85 |
1 |
p. 33-45 |
artikel |
26 |
The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approach
|
Sentürk, Melih |
|
|
85 |
1 |
p. 33-45 |
artikel |